Key result
A 6-month Mobile Health (mHealth) intervention significantly improved systolic blood pressure decrease (p=0.01) and BP monitoring adherence compared with standard follow-up.
Why the study?
The study examined the effectiveness of an mHealth intervention for hypertension self-monitoring and management in an underserved urban community.
Does a Mobile Health (mHealth) intervention improve blood pressure and adherence in patients with hypertension in an underserved urban community?
RCT (n=30)
Randomly assigned
Does a Mobile Health (mHealth) intervention improve blood pressure and adherence in patients with hypertension in an underserved urban community?
p-value: p=0.01
A 6-month mHealth intervention significantly improved systolic blood pressure and medication adherence self-efficacy in an underserved urban community.
Supports mHealth adoption in underserved hypertension care; extends RCT evidence for digital tools improving BP and adherence.
This 6-month pilot randomized controlled trial examined the effectiveness of a Mobile Health (mHealth) intervention for hypertension self-monitoring and management in an underserved urban community. The four health outcomes measured included changes in systolic and diastolic blood pressure (BP), BP monitoring adherence, perceived medication adherence self-efficacy, and health-related quality of life. Thirty participants were randomly assigned to the mHealth group or a standard follow-up group; 25 participants completed the study. The mHealth group had statistically significant improvement in systolic BP decrease ( p = .01). The mHealth group had better adherence to BP monitoring and improved perceived medication adherence self-efficacy at 6 months, compared with the standard follow-up group. The results suggest that an mHealth intervention has the potential to facilitate hypertension management in underserved urban communities.
No takes yet. Share an insight, caveat, or question.
Zha et al. (2019) conducted an RCT in Hypertension (n=30). Mobile Health (mHealth) intervention vs. Standard follow-up was evaluated on Changes in systolic and diastolic blood pressure, BP monitoring adherence, perceived medication adherence self-efficacy, and health-related quality of life (p=0.01). A 6-month Mobile Health (mHealth) intervention significantly improved systolic blood pressure decrease (p=0.01) and BP monitoring adherence compared with standard follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: